Spike protein

Spike protein

Spike protein Overview

Molecule Name
Coronavirus spike glycoprotein
Synonyms
Spike,S protein,Spike glycoprotein,S glycoprotein
Drug Development Progress
Drugs in Clinical Trials91
Approved Drugs15
Highest Development StageApproved
Target Synonym
Spike glycoprotein,E2,Peplomer protein,S,SARS-CoV-2 S protein
Background
It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

Spike protein Product List

Species
  • SARS-CoV-2(71)
  • Bat coronavirus(7)
  • HCoV-229E(2)
  • HCoV-HKU1(2)
  • MERS(2)
  • Pangolin coronavirus(2)
  • SARS(2)
  • SARS coronavirus SZ1(2)
  • Bat coronavirus Anlong103(1)
  • Bat coronavirus BANAL20-236(1)
  • Bat coronavirus RS4081(1)
  • Bat SARS-like coronavirus isolate Rs4084(1)
  • Bat SARS-like coronavirus isolate Rs7327(1)
  • Bat SARS-like coronavirus WIV1(1)
  • HCoV-NL63(1)
  • HCoV-OC43(1)
  • Rhinolophus affinis coronavirus isolate LYRa11(1)
  • SARS coronavirus frankfult-1(1)
  • SARS coronavirus GD03T0013(1)
  • SARS coronavirus GZ-C(1)
  • SARS coronavirus PC4-127(1)
  • SARS coronavirus PC4-13(1)
  • SARS coronavirus PC4-137(1)
  • SARS coronavirus Sino1-11(1)
  • SARS coronavirus Urbani(1)
  • SARS-CoV(1)
  • SARS-CoV BtKY72(1)
  • SARS-CoV GD01(1)
Tag
  • His Tag(87)
  • His Tag & Avi Tag(23)
Host
  • HEK293(109)
  • InsectCells(1)
Conjugate
  • Unconjugated(87)
  • Biotin-labeled(23)
Grade
  • RUO(110)
Low Endotoxin
  • No(110)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&Price
Spike protein
HOTAvitag
SPN-C82E3
Biotinylated SARS-CoV-2 S protein (D614G), His,Avitag™, Super stable trimer (MALS verified)
SARS-CoV-2
HEK293
MALSSDS-PAGE
ELISA

$565.00

25ug
Spike protein
SARS-CoV-2 Spike Trimer Protein, His Tag (JN.1/Omicron) (MALS verified)
SARS-CoV-2
HEK293
MALSSDS-PAGE
ELISA

$465.00

50ug
Spike protein
HOTAvitag
SPN-C82E9
Biotinylated SARS-CoV-2 S protein, His,Avitag™, Super stable trimer (MALS verified)
SARS-CoV-2
HEK293
MALSSDS-PAGE
ELISASPR

$565.00

25ug
Spike protein
SARS-CoV-2 S protein, His Tag, Super stable trimer (MALS verified)
SARS-CoV-2
HEK293
MALSSDS-PAGE
ELISASPR

$465.00

50ug
Spike protein
Bat coronavirus hCoV-19/bat/Yunnan/RmYN02/2019 Spike Trimer Protein (R640A, KV940-941PP), His Tag
Bat coronavirus
HEK293
SDS-PAGE

$465.00

50ug
Spike protein
Bat coronavirus RaTG13 Spike Trimer Protein (R681A, KV982-983PP), His Tag
Bat coronavirus
HEK293
SDS-PAGE
ELISA

$465.00

50ug
Spike protein
Bat coronavirus Cp/Yunnan2011 Spike Trimer Protein (R653A, KV954-955PP), His Tag (MALS verified)
Bat coronavirus
HEK293
MALSSDS-PAGE

$465.00

50ug
Spike protein
Bat SARS-like coronavirus Khosta-2 Spike Trimer Protein (R666A, KV966-967PP), His Tag
Bat coronavirus
HEK293
SDS-PAGE
ELISA

$465.00

50ug
Spike protein
Bat coronavirus HKU3 (BtCoV) (SARS-like coronavirus HKU3) Spike Trimer Protein (R654A, KV955-956PP), His Tag (MALS verified)
Bat coronavirus
HEK293
MALSSDS-PAGE

$465.00

50ug
Spike protein
Bat SARS-like coronavirus RsSHC014 Spike Trimer Protein (R668A, KA969-970PP), His Tag (MALS verified)
Bat coronavirus
HEK293
MALSSDS-PAGE
ELISA

$465.00

50ug
You Have Viewed 1-10 Of 110 Results
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 11

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
VLPCOV-05VLPCOV-05Phase 3 ClinicalVlp Therapeutics
Coronavirus Disease 2019 (COVID-19)
Details
VLPCOV-04VLPCOV-04Phase 3 ClinicalVlp Therapeutics
Coronavirus Disease 2019 (COVID-19)
Details
BamlanivimabLY-3819253Phase 3 ClinicalAbCellera Biologics Inc, Eli Lilly And Company
Coronavirus Disease 2019 (COVID-19); Coronavirus Infections
Details
mRNA-1273.231mRNA-1273.231Phase 3 ClinicalModerna Inc
Coronavirus Disease 2019 (COVID-19)
Details
mRNA-1273.815mRNA-1273.815Phase 3 ClinicalModerna Inc
Coronavirus Disease 2019 (COVID-19)
Details
RiltozinameranPhase 3 ClinicalBiontech Se, Pfizer Inc
Coronavirus Disease 2019 (COVID-19)
Details
YKYY-017YKYY-017Phase 3 ClinicalYoucare Pharmaceutical Group Co Ltd
Coronavirus Disease 2019 (COVID-19)
Details
AZD-5156AZD-5156; Cilgavimab/AZD 3152Phase 3 ClinicalAstrazeneca Plc
Coronavirus Disease 2019 (COVID-19)
Details
abdavomeranBNT162b1Phase 3 ClinicalBiontech Se
Coronavirus Disease 2019 (COVID-19); Drug-Related Side Effects and Adverse Reactions; Respiratory Tract Infections; RNA Virus Infections; Virus Diseases
Details
Recombinant SARS-CoV-2 tetravalent(Alpha/Beta variant) S-trimer protein vaccine (SinoCelltech)SCTV-01-EPhase 3 ClinicalSinoCelltech Ltd
Coronavirus Disease 2019 (COVID-19)
Details
GSK-4362620AGSK-4362620APhase 3 ClinicalGsk Vaccines Gmbh, Medicago Inc
Coronavirus Disease 2019 (COVID-19)
Details
Recombinant SARS-CoV-2 bivalent (Alpha/Beta variant) S-trimer protein vaccine (SinoCelltech)SCTV-01-CPhase 3 ClinicalSinoCelltech Ltd
Coronavirus Disease 2019 (COVID-19)
Details
Ogalvibart/CrexavibartBMS-986414/C 144LS; C 144LS/BMS-986414; BMS-986414 + BMS-986413; C 144LS/IM051; C 144LS/ogalvibart; C-135-LS/C-144-LS; C-144-LS/C-135-LS; IM051/C 144LSPhase 3 ClinicalBristol Myers Squibb Srlcompany, The Rockefeller University
Coronavirus Disease 2019 (COVID-19); Coronavirus Infections
Details
ImdevimabRG-6412Phase 3 ClinicalF. Hoffmann-La Roche Ltd
Coronavirus Disease 2019 (COVID-19)
Details
ABP-300ABP-300; MW-05(Mabwell/Abpro)Phase 3 ClinicalAbpro Corp, Mabwell (Shanghai) Bioscience Co Ltd
Coronavirus Disease 2019 (COVID-19)
Details
EnsovibepMP-0420Phase 3 ClinicalMolecular Partners Ag
Coronavirus Disease 2019 (COVID-19)
Details
UpanovimabHB-27; SCTA-01Phase 3 ClinicalSinoCelltech Ltd
Coronavirus Disease 2019 (COVID-19)
Details
STI-2099STI-2099Phase 2 ClinicalSorrento Therapeutics Inc
Coronavirus Disease 2019 (COVID-19)
Details
BNT162a1Phase 2 ClinicalBiontech Se
Coronavirus Disease 2019 (COVID-19); Drug-Related Side Effects and Adverse Reactions; Respiratory Tract Infections; RNA Virus Infections; Virus Diseases
Details
PidacmeranBNT162c2Phase 2 ClinicalBiontech Se
Coronavirus Disease 2019 (COVID-19); Drug-Related Side Effects and Adverse Reactions; Respiratory Tract Infections; RNA Virus Infections; Virus Diseases
Details
Recombinant SARS-CoV-2 Beta/Omicron (BA.1/BQ.1.1/XBB.1) S-trimer protein vaccine (SinoCelltech)SCTV01E-2Phase 2 ClinicalSinoCelltech Ltd
Coronavirus Disease 2019 (COVID-19)
Details
SA-55SA55; SA-55; BD55-5514Phase 2 ClinicalSinovac Biotech Co Ltd
Coronavirus Disease 2019 (COVID-19)
Details
Reluscovtogene ralaplasmidINO-4800; INO4800; PGX-9501Phase 2 ClinicalInovio Pharmaceuticals Inc
Coronavirus Disease 2019 (COVID-19); Coronavirus Infections; Hepatitis B, Chronic
Details
BM-219BM-219; BM219Phase 2 ClinicalSuzhou Biomissile Pharmaceuticals Co Ltd
Coronavirus Disease 2019 (COVID-19)
Details
SARS-CoV-2 mRNA Vaccine(Argorna)RBMRNA-176Phase 2 ClinicalArgorna Pharmaceuticals Ltd
Coronavirus Disease 2019 (COVID-19)
Details
Recombinant SARS-CoV-2 Vaccine(variant)(Shanghai Zerun)Phase 2 ClinicalShanghai Zerun Biotechnology Co Ltd
Coronavirus Disease 2019 (COVID-19)
Details
COVID-19 mRNA Vaccine(Cnbg-Virogin)ZSVG-02-OPhase 2 ClinicalCnbg-Virogin Biotech (Shanghai) Ltd
Coronavirus Disease 2019 (COVID-19)
Details
FBR-002FBR-002Phase 2 ClinicalFabentech
Coronavirus Disease 2019 (COVID-19)
Details
IBIO123IBIO-123Phase 2 ClinicalImmune Biosolutions Inc
Coronavirus Disease 2019 (COVID-19)
Details
BebtelovimabLY-CoV1404 monoclonal antibody; LY-3853113; LY-CoV 1404 mAb; LY-CoV1404Phase 2 ClinicalEli Lilly And Company
Coronavirus Disease 2019 (COVID-19)
Details
ChAd-triCoVChAd-triCoV; ChAd-triCoV/MacPhase 2 ClinicalCanadian Institutes Of Health Research (Cihr), Mcmaster University
Coronavirus Disease 2019 (COVID-19)
Details
CasirivimabRG-6413Phase 2 ClinicalF. Hoffmann-La Roche Ltd
Coronavirus Disease 2019 (COVID-19)
Details
LY-CovMabLY-CovMabPhase 2 ClinicalLuye Pharma Group Ltd
Coronavirus Disease 2019 (COVID-19)
Details
COR-101STE90-C11Phase 2 ClinicalCorat Therapeutics Gmbh
Coronavirus Disease 2019 (COVID-19)
Details
GLS-5310GLS-5310Phase 2 ClinicalGeneone Life Science Inc
Coronavirus Disease 2019 (COVID-19)
Details
BGB-DXP604DXP-604; BGB-DXP604Phase 2 ClinicalSinglomics Biopharmaceuticals Co Ltd
Coronavirus Disease 2019 (COVID-19)
Details
LomtegovimabBI-767551Phase 2 ClinicalGerman Center For Infection Research, University Of Cologne
Coronavirus Disease 2019 (COVID-19)
Details
Equine immunoglobulin anti SARS-CoV-2 (Caja Costarricense de Seguro Social)Phase 2 ClinicalUniversidad De Costa Rica
Coronavirus Disease 2019 (COVID-19)
Details
ChulaCov19 mRNA vaccinePhase 2 ClinicalChulalongkorn University
Coronavirus Disease 2019 (COVID-19)
Details
DXP-593BGB DXP593; DXP-593Phase 2 ClinicalSinglomics Biopharmaceuticals Co Ltd
Coronavirus Disease 2019 (COVID-19)
Details
EtesevimabLY-CoV016; LY-CoV-016; JS-016; LY-3832479Phase 2 ClinicalInstitute Of Microbiology Of Chinese Academy Of Sciences, Shanghai Junshi Biosciences Co Ltd
Coronavirus Disease 2019 (COVID-19); Severe Acute Respiratory Syndrome
Details
NeomiVacPhase 1 ClinicalNeovacs
Coronavirus Disease 2019 (COVID-19)
Details
AT-301 (Atossa Therapeutics)AT-301A; AT-301BPhase 1 ClinicalAtossa Therapeutics Inc
Coronavirus Disease 2019 (COVID-19)
Details
recombinant SARS-CoV-2 S-trimer vaccine (Binhui Biopharmaceutical)Phase 1 ClinicalWuhan Binhui Biotechnology Co Ltd
Coronavirus Disease 2019 (COVID-19)
Details
DNA-based mAbs (Inovio/AstraZeneca/Wistar Institute/University of Pennsylvania/Indiana University)dMAb-1; dMAb; dMAb-2Phase 1 ClinicalInovio Pharmaceuticals Inc
Coronavirus Disease 2019 (COVID-19)
Details
SARS-CoV-2 vaccine (The Scientific and Technological Research Council of Turkey)Phase 1 ClinicalThe Scientific And Technological Research Council Of Turkey
Coronavirus Disease 2019 (COVID-19)
Details
SARS-CoV-2 specific cytotoxic T lymphocytes (M.D. Anderson Cancer Center)Phase 1 ClinicalThe University Of Texas MD Anderson Cancer Center
Coronavirus Disease 2019 (COVID-19); Pneumonia, Viral; Respiratory Distress Syndrome, Adult
Details
RBD protein vaccinePhase 1 ClinicalCopyright The Peter Doherty Institute For Infection And Immunity
Coronavirus Disease 2019 (COVID-19)
Details
SPK-002SPK-002Phase 1 ClinicalInstituto Pasteur
Coronavirus Disease 2019 (COVID-19)
Details
Hexapro-based SARS-CoV-2 vaccine  (Vaxxas/University of Queensland)Phase 1 ClinicalThe University Of Queensland
Coronavirus Disease 2019 (COVID-19)
Details
COVID-19 vacine targeting SARS-CoV-2 spike protein RBD (Monash Institute of Pharmaceutical Sciences/Burnet Institute)Phase 1 ClinicalMonash Institute of Pharmaceutical Sciences
Coronavirus Disease 2019 (COVID-19)
Details
COReNAPCINPhase 1 ClinicalRenap Industrial Group
Coronavirus Disease 2019 (COVID-19)
Details
AVACC-10AVACC-10Phase 1 ClinicalIntravacc
Coronavirus Disease 2019 (COVID-19)
Details
LMN-301LMN301Phase 1 ClinicalLumen Bioscience Inc
Coronavirus Disease 2019 (COVID-19)
Details
BAT-2022BAT-2022Phase 1 ClinicalBio-Thera Solutions Ltd
Coronavirus Disease 2019 (COVID-19)
Details
CV-2-CoVCV-2-CoVPhase 1 ClinicalCurevac Ag, Glaxosmithkline Spa
Coronavirus Disease 2019 (COVID-19)
Details
SCB-2020SSCB-2020SPhase 1 ClinicalClover Biopharmaceuticals Aus Pty Ltd
Coronavirus Disease 2019 (COVID-19)
Details
IN-006IN-006Phase 1 ClinicalInhalon Biopharma Inc
Coronavirus Disease 2019 (COVID-19)
Details
SW-0123SW-0123; DF-104B1Phase 1 ClinicalStemirna Therapeutics
Coronavirus Disease 2019 (COVID-19)
Details
PDI-204PDI-204; PDI204Phase 1 ClinicalUniversity Of Melbourne
Coronavirus Disease 2019 (COVID-19)
Details
Regdanvimab/CT-P63Phase 1 ClinicalCelltrion Inc
Coronavirus Disease 2019 (COVID-19)
Details
AER-001 (Aerium Therapeutics)AER-001Phase 1 ClinicalCentre Hospitalier Universitaire Vaudois, Swiss Federal Institute Of Technology
Coronavirus Disease 2019 (COVID-19)
Details
ABBV-2B04ABBV-2B04Phase 1 ClinicalAbbvie Inc, Washington University
Coronavirus Disease 2019 (COVID-19)
Details
RBMRNA-405RBMRNA-405Phase 1 ClinicalArgorna Pharmaceuticals Ltd
Coronavirus Disease 2019 (COVID-19)
Details
GB-0669GB-0669Phase 1 ClinicalGenerate Biomedicines Inc
Coronavirus Disease 2019 (COVID-19)
Details
PA-001 (PeptiDream)PA-001Phase 1 ClinicalPeptiDream Inc
Coronavirus Disease 2019 (COVID-19)
Details
REGN17092REGN-17092; REGN17092Phase 1 ClinicalRegeneron Pharmaceuticals Inc
Details
B/HPIV3/S-6PB/HPIV-3/S-6-PPhase 1 ClinicalNational Institutes Of Health
Coronavirus Disease 2019 (COVID-19)
Details
F-61F-61Phase 1 ClinicalWuhan Institute Of Biological Products Co Ltd
Coronavirus Disease 2019 (COVID-19)
Details
GRT-R-918GRT-R918; GRT-R-918Phase 1 ClinicalGritstone Bio Inc
Coronavirus Disease 2019 (COVID-19)
Details
GRT-R-914GRT-R914; GRT-R-914Phase 1 ClinicalGritstone Bio Inc
Coronavirus Disease 2019 (COVID-19)
Details
GRT-R-912GRT-R912; GRT-R-912Phase 1 ClinicalGritstone Bio Inc
Coronavirus Disease 2019 (COVID-19)
Details
MTx-COVAB36MTx-COVAB36Phase 1 ClinicalMemo Therapeutics AG
Coronavirus Disease 2019 (COVID-19)
Details
GorivitugREGN-15160Phase 1 ClinicalRegeneron Pharmaceuticals Inc
Details
SI-F019SI-F019; F-019; SZ-F019Phase 1 ClinicalSichuan Baili Pharmaceutical Co Ltd
Details
CT-P63CT-P-63; CT-P63Phase 1 ClinicalCelltrion Inc
Coronavirus Disease 2019 (COVID-19)
Details
JS-026JS-026Phase 1 ClinicalShanghai Junshi Biosciences Co Ltd
Coronavirus Disease 2019 (COVID-19)
Details
Ad5-triCoV/MacAd5-triCoV/MacPhase 1 ClinicalCanadian Institutes Of Health Research (Cihr), Mcmaster University
Coronavirus Disease 2019 (COVID-19)
Details
JMB-2002JMB-2002Phase 1 ClinicalJiangxi Jemincare Group Co Ltd
Coronavirus Disease 2019 (COVID-19)
Details
SimaravibartMAD-0004J08Phase 1 ClinicalFondazione Toscana Life Sciences
Coronavirus Disease 2019 (COVID-19)
Details
OgalvibartBMS-986414Phase 1 ClinicalBristol Myers Squibb Srlcompany, The Rockefeller University
Coronavirus Disease 2019 (COVID-19)
Details
CrexavibartC144-LS; C144LS; BMS-986413Phase 1 ClinicalBristol Myers Squibb Srlcompany, The Rockefeller University
Coronavirus Disease 2019 (COVID-19)
Details
ABBV-47D11HBM9022; ABBV-47D11; HBM-9022; 47D11Phase 1 ClinicalAbbvie Inc
Coronavirus Disease 2019 (COVID-19)
Details
EnuzovimabHFB-3013; HFB30132APhase 1 ClinicalHiFiBiO Therapeutics
Coronavirus Disease 2019 (COVID-19)
Details
ADM-03820Phase 1 ClinicalOlogy Bioservices Inc
Coronavirus Disease 2019 (COVID-19)
Details
HLX-71HLX-71Phase 1 Clinical
Coronavirus Disease 2019 (COVID-19)
Details
SARS-COV2 vaccine (DreamTec Research)ClinicalDreamTec Research Ltd
Coronavirus Disease 2019 (COVID-19); Pneumonia
Details
Recombinant Omicron-Delta COVID-19 Vaccine (CHO Cell)ClinicalAnhui Zhifei Longcom Biopharmaceutical Co Ltd
Coronavirus Disease 2019 (COVID-19)
Details
SA-58SA-58ClinicalSinovac Life Sciences Co Ltd
Coronavirus Disease 2019 (COVID-19)
Details
AAHI-SC2AAHI-SC2Immunitybio Inc
Details
HY-3000HY-3000Hybio Pharmaceutical Co Ltd
Coronavirus Disease 2019 (COVID-19)
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
TozinameranBNT162b2; PF-07302048; BNT-161b1; BNT162; Bnt-162b2; BNT162b2SA; BNT-162b5ApprovedBiontech Se, Pfizer Inc复必泰, 復必泰, ComirnatyUnited KingdomCoronavirus Disease 2019 (COVID-19)Biontech Se2020-12-02
Anaphylaxis; Coronavirus Disease 2019 (COVID-19); Coronavirus Infections; Drug-Related Side Effects and Adverse Reactions; Infections; Influenza, Human; Neoplasms; Respiratory Tract Infections; RNA Virus Infections; Severe Acute Respiratory Syndrome; Virus Diseases
Details
Recombinant novel coronavirus vaccine (adenovirus type 5 vector) (CanSinoBio)ApprovedChinese Academy Of Military Medical Sciences, Tianjin Cansino Biotechnology Inc克威莎, Convidecia, Convidecia AirMainland ChinaCoronavirus Disease 2019 (COVID-19)Tianjin Cansino Biotechnology Inc2021-02-25
Coronavirus Disease 2019 (COVID-19)
Details
Tozinameran/famtozinameranApprovedBioNTech Manufacturing GmbHCanadaCoronavirus Disease 2019 (COVID-19)BioNTech Manufacturing GmbH2022-10-11
Coronavirus Disease 2019 (COVID-19)
Details
Recombinant COVID-19 Trivalent (XBB.1.5+BA.5+Delta) Protein Vaccine (Sf9 Cell)(Chengdu WestVac)WSK-V102CApprovedChengdu WestVac Biopharma Co Ltd, West China Hospital Of Sichuan University威克欣®3价XBB疫苗Mainland ChinaCoronavirus Disease 2019 (COVID-19)West China Hospital Of Sichuan University, Chengdu WestVac Biopharma Co Ltd2023-06-08
Coronavirus Disease 2019 (COVID-19)
Details
Recombinant COVID-19 Protein Vaccine (Sf9 Cell) (Chengdu WestVac)WSK-V101ApprovedChengdu WestVac Biopharma Co Ltd威克欣Mainland ChinaCoronavirus Disease 2019 (COVID-19)Chengdu WestVac Biopharma Co Ltd, West China Hospital Of Sichuan University2022-12-05
Coronavirus Disease 2019 (COVID-19)
Details
Gam-COVID-VacApprovedGamaleya Research Institute Of Epidemiology And Microbiology, Gamaleya Research Institute Of Epidemiology And Microbiology, Health Ministry Of The Russian FederationSputnik VRussian FederationCoronavirus Disease 2019 (COVID-19)Gamaleya Research Institute Of Epidemiology And Microbiology2020-08-11
Coronavirus Disease 2019 (COVID-19); Coronavirus Infections
Details
SipavibartAZD3152; AZD-3152ApprovedRQ Biotechnology LtdKavigaleJapanCoronavirus Disease 2019 (COVID-19)Astrazeneca Kk2024-12-27
Coronavirus Disease 2019 (COVID-19)
Details
PemivibartVYD-222ApprovedInvivyd IncPEMGARDA, PemgardaUnited StatesCoronavirus Disease 2019 (COVID-19)Invivyd Inc2025-03-05
Coronavirus Disease 2019 (COVID-19)
Details
Casirivimab/imdevimabREGN-10933+REGN-10987; RG-6413+RG6412; REGEN-COV-2; REGN-COV2; REGN-COV-2; REGEN-COVApprovedF. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Incロナプリーブ, REGEN-COV, RONAPREVEJapanCoronavirus Disease 2019 (COVID-19)Chugai Pharmaceutical Co Ltd2021-07-19
Chronic Disease; Coronavirus Disease 2019 (COVID-19); Coronavirus Infections; Rejection of organ transplantation
Details
Tixagevimab/CilgavimabAZD-7442; AZD7442ApprovedVanderbilt University Medical CenterEvusheld, 恩适得United KingdomCoronavirus Disease 2019 (COVID-19)Astrazeneca Uk Ltd2022-03-16
Coronavirus Disease 2019 (COVID-19); Coronavirus Infections; Leukemia, Lymphocytic, Chronic, B-Cell
Details
SotrovimabVIR-7831; GSK-4182136ApprovedVir Biotechnology IncXevudyAustraliaCoronavirus Disease 2019 (COVID-19)Vir Biotechnology Inc2021-08-23
Coronavirus Disease 2019 (COVID-19); Hematologic Neoplasms; Lymphoma; Solid tumours
Details
RegdanvimabCT-P59ApprovedCelltrion IncRegkironaSouth KoreaCoronavirus Disease 2019 (COVID-19)Celltrion Inc2021-09-18
Coronavirus Disease 2019 (COVID-19)
Details
AmubarvimabBRII-196; BRII196ApprovedBrii Biosciences (Beijing) Co LtdMainland ChinaCoronavirus Disease 2019 (COVID-19)Brii Biosciences (Shanghai) Co Ltd2021-12-08
Coronavirus Disease 2019 (COVID-19); Coronavirus Infections
Details
RomlusevimabBRII198; BRII-198ApprovedBrii Biosciences (Beijing) Co LtdMainland ChinaCoronavirus Disease 2019 (COVID-19)Brii Biosciences (Shanghai) Co Ltd2021-12-08
Coronavirus Disease 2019 (COVID-19); Coronavirus Infections
Details
Recombinant SARS-CoV-2 vaccine (CHO Cell) (Zhifei Longcom Biopharmaceutical)ZF2001ApprovedAnhui Zhifei Longcom Biopharmaceutical Co Ltd, Institute Of Microbiology Of Chinese Academy Of Sciences智克威得UzbekistanCoronavirus Disease 2019 (COVID-19)Anhui Zhifei Longcom Biopharmaceutical Co Ltd2021-03-01
Coronavirus Disease 2019 (COVID-19); Coronavirus Infections
Details
Customer Reviews
  • M***s2025-02-07
    We ordered this peptide to use with klickmers from Immudex to look at immune response to COVID in cancer patients. We were very satisfied with the specific staining we achieved and the excellent customer service received. The product was straightforward to reconstitute and arrived very quickly (UK). The QR code with the vial allows quick access to the CoA and useful information about the product.
  • M***g2022-05-07
    This product was purchased to conduct plasma screens for anti-SARS-CoV-2 antibodies and perform antibody monoclonal antibody binding/capture studies on BLI. This product came out in a timely manner following its designation as a VOC and was delivered quickly. The protein produced high quality and consistent results in both MSD and BLI experiments and is remarkably stable at 4C where it was stored for approximately 3 weeks without any appreciable change in experimental result.
  • A***r2021-09-28
    We bought an array or anti bodies and associated proteins to do testing for pull down and binding efficiency in a couple different assays. Then compared with our technology for binding comparisons. The proteins and anti bodies were relatively high in concentration and worked well for the experiments where the results were consistent and reproducible (which was the entire hope for the experiment from the start.) Working with ACRO is very easy and we will be ordering from them more in the future
  • A***r2021-09-03
    We ordered this product to do Antibody, Protein/target, aptamer tests for binding to different epitopes as well a mix of general binding experiments in different mediums. The speed of delivery of the product was extremely quick and came in a nice package (I like the recyclable cooler boxes). The product is pure from our initial experiments and fills our needs perfectly.
  • S***a2021-08-18
    We use Acro's products to evaluate our vaccine against different SARS-CoV-2 variants. In our research, Acro's products have been used in immunological assays such as ELISA, MSD, and Enzyme-linked Immunospot (ELISpot). We have received robust results with their proteins and we plan to continue to purchase other SARS-CoV-2 proteins as well. We also appreciate how fast their products arrive! I have also asked for assistance with ordering in the past and I received a very quick response from their representatives.